Acumen Pharmaceuticals Q1 2026 Earnings Narrowed Loss Surprises as Alzheimers Pipeline Advances KTCC Q1 2026 Earnings Loss Per Share of 026 as Stock Declines POWL Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds Senate Delays Funding for Trump Ballroom Vote Postponed Until June Amid Immigration Package Debate Cramer Offers Market Insights During Investing Club Morning Meeting Sector Preferences and Stock Potential Discussed AHRT Q1 2026 Earnings EPS Misses Estimates by 164 Stock Rises Slightly Heartland Express Q1 2026 Earnings EPS Loss Narrows Beats Consensus by Nearly 50